Amgen Inc.NASDAQ: AMGN

Approach to AI-Enabled Clinical Development

· Issued by Amgen Inc.
Amgen's next earnings callAmgen (NASDAQ:AMGN) Q3 2026 Earnings Call · Nov 3, 2026 at 4:30 PM ESTRegister
The path from molecule to medicine is among the most demanding in science-a long, complex journey where every delay and setback is felt most by patients who are waiting for new treatments. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Amgen Inc. on 6ix

Earlier from Amgen

Later from Amgen

All Amgen news releases